Methods for analysis of urinary glycosaminoglycans
- PMID: 3062022
- DOI: 10.1016/s0378-4347(00)83875-x
Methods for analysis of urinary glycosaminoglycans
Abstract
Methods for the analysis of urinary GAGs that can be used for or are applicable to routine assays are described. The most popular method for isolation of GAGs from a urine sample is CPC precipitation, in spite of the fact that it is time-consuming. To identify the different types of GAGs excreted, separation by one-dimensional cellulose acetate electrophoresis followed by staining with alcian blue or toluidine blue may suffice for routine purposes. Solvents such as barium acetate, calcium acetate, barbital buffer and pyridine-formic acid are used for the separation. However, the separation of the seven types of GAGs by conventional one-dimensional electrophoresis is difficult, and a discontinuous electrophoretic method with barium acetate buffer and barium acetate buffer containing ethanol has proved effective for the separation. HPLC separation methods are used for assaying the profiles of enzymatic digestion products of GAGs. Advanced HPLC methods for separating intact GAGs of different types are currently unavailable. Unsaturated disaccharides produced with heparitinase and/or heparinase from heparan sulphate and oligosaccharides produced by hyaluronidase digestion of hyaluronic acid can be separated by HPLC. For chondroitin sulphate isomers, unsaturated disaccharides produced by digestion of the samples with chondroitinase ABC or chondroitinase AC are separated by HPLC and determined by their UV absorbance or by fluorescence labelling. Highly sensitive quantitation of chondroitin sulphate isomers is possible by these methods, which are also efficient for the investigation of the constituents of GAG polymers. Some of these methods have been applied to urine samples from patients with, e.g., mucopolysaccharidoses.
Similar articles
-
Separation of reduced disaccharides derived from glycosaminoglycans by high-performance liquid chromatography.J Chromatogr. 1981 Jul 24;212(1):65-73. doi: 10.1016/s0021-9673(00)80547-6. J Chromatogr. 1981. PMID: 6790557
-
Novel simultaneous analysis of 18 types of glycosaminoglycan-derived disaccharides using 4-aminobenzoic acid ethyl ester derivatization by HPLC with fluorescence detection.Anal Bioanal Chem. 2024 Nov;416(28):6209-6221. doi: 10.1007/s00216-024-05504-5. Epub 2024 Aug 30. Anal Bioanal Chem. 2024. PMID: 39212700
-
HPLC glycosaminoglycan analysis in patients with Graves' disease.Clin Sci (Lond). 1997 May;92(5):511-7. doi: 10.1042/cs0920511. Clin Sci (Lond). 1997. PMID: 9176026
-
High-performance liquid chromatographic analysis of glycosaminoglycan-derived oligosaccharides.J Chromatogr A. 1996 Jan 12;720(1-2):275-93. doi: 10.1016/0021-9673(95)00338-x. J Chromatogr A. 1996. PMID: 8601196 Review.
-
Extracellular mammalian polysaccharides: glycosaminoglycans and proteoglycans.J Chromatogr. 1987 Jul 17;418:187-222. doi: 10.1016/0378-4347(87)80009-9. J Chromatogr. 1987. PMID: 3305540 Review.
Cited by
-
Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate.Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):245-51. Biochem J. 2000. PMID: 10926850 Free PMC article.
-
Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.Cell Mol Neurobiol. 2008 Nov;28(7):1005-15. doi: 10.1007/s10571-008-9274-1. Epub 2008 Mar 19. Cell Mol Neurobiol. 2008. PMID: 18350378 Free PMC article.
-
Advances in glycosaminoglycan detection.Mol Genet Metab. 2020 Jun;130(2):101-109. doi: 10.1016/j.ymgme.2020.03.004. Epub 2020 Mar 27. Mol Genet Metab. 2020. PMID: 32247585 Free PMC article. Review.